GlaxoSmithKline PLC Director/PDMR Shareholding (8405O)
13 October 2021 - 1:17AM
UK Regulatory
TIDMGSK
RNS Number : 8405O
GlaxoSmithKline PLC
12 October 2021
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms E Walmsley
=== ============================ =================================================
b) Position/status Chief Executive Officer
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.9739 9 (partnership shares)
=== ============================ ============== =============================
GBP13.9739 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =================================================
e) Date of the transaction 2021-10-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr R Connor
=== ============================ =================================================
b) Position/status President, Vaccines & Global Health
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.9739 9 (partnership shares)
=== ============================ ============== =============================
GBP13.9739 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =================================================
e) Date of the transaction 2021-10-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms D Conrad
=== ============================ =================================================
b) Position/status SVP, Human Resources
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.9739 9 (partnership shares)
=== ============================ ============== =============================
GBP13.9739 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =================================================
e) Date of the transaction 2021-10-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr J Ford
=== ============================ =================================================
b) Position/status SVP and General Counsel
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.9739 9 (partnership shares)
=== ============================ ============== =============================
GBP13.9739 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =================================================
e) Date of the transaction 2021-10-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms S Jackson
=== ============================ =================================================
b) Position/status SVP, Global Communications and CEO Office
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.9739 9 (partnership shares)
=== ============================ ============== =============================
GBP13.9739 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =================================================
e) Date of the transaction 2021-10-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Mr D Jackson
=== ============================ =====================================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
and CEO Office)
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GlaxoSmithKline plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP13.9739 9 (partnership shares)
=== ============================ ================ ===============================
GBP13.9739 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =====================================================
e) Date of the transaction 2021-10-11
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr D Redfern
=== ============================ =================================================
b) Position/status Chief Strategy Officer
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.9739 9 (partnership shares)
=== ============================ ============== =============================
GBP13.9739 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =================================================
e) Date of the transaction 2021-10-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr R Simard
=== ============================ =================================================
b) Position/status President, Pharmaceuticals Supply Chain
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.9739 9 (partnership shares)
=== ============================ ============== =============================
GBP13.9739 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =================================================
e) Date of the transaction 2021-10-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr P Thomson
=== ============================ =================================================
b) Position/status President, Global Affairs
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.9739 9 (partnership shares)
=== ============================ ============== =============================
GBP13.9739 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =================================================
e) Date of the transaction 2021-10-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms D Waterhouse
=== ============================ =================================================
b) Position/status Chief Executive Officer of ViiV Healthcare
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.9739 9 (partnership shares)
=== ============================ ============== =============================
GBP13.9739 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =================================================
e) Date of the transaction 2021-10-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms V Whyte
=== ============================ =================================================
b) Position/status Company Secretary
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.9739 9 (partnership shares)
=== ============================ ============== =============================
GBP13.9739 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.9739
=== ============================ =================================================
e) Date of the transaction 2021-10-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHZLLFFFBLFFBZ
(END) Dow Jones Newswires
October 12, 2021 10:17 ET (14:17 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Jan 2025 to Feb 2025
Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Feb 2025
